Novartis

Novartis

Traded as NYSE: NVS
Industry Drug Manufacturers – Major
Founded 1996
Headquarters Basel 4056, Switzerland
CEO
Mr. Joseph Jimenez
Revenue US$ 50.387 billion
Operating income
US$ 8.977 billion
Net income
US$ 17.794 billion
Total assets US$ 131.556 billion
Total equity US$ 77.046 billion
Number of employees
118.000
Website Novartis.com
Source
Novartis.com

About:

 

Novartis AG,

is a biotechnology and pharmaceutical company based in Basel, Switzerland. The company was created in 1996 from the merger of “Ciba-Geigy AG” and “Sandoz”. Novartis goes back to several Basler tar-colour producers who joined together over the time to Novartis. Today, Novartis is the world’s largest pharmaceutical company and has, under the current CEO Joseph Jimenez, 118000 employees and a revenue of 50.387 billion USD.

Operation divisions: Pharmaceuticals (Consumer health and animal health)

Since 1996, Novartis has engaged in a number of M&A deals: 106 transactions with a value of USD 107.83 bil. (for number and value per year, see figure below).

M&A Novartis

Top 10 Deals Novartis

Rank Date Target Nation Value (in bil. USD) Status
1 04.07.2008 Alcon Inc Switzerland 27.73 Completed
2 04.22.2014 GlaxoSmithKline PLC Oncology United Kingdom 16.00 Completed
3 01.04.2010 Alcon Inc Switzerland 12.14 Completed
4 04.07.2008 Alcon Inc Switzerland 10.55 Completed
5 09.01.2005 Chiron Corp United States 6.21 Completed
6 02.21.2005 Hexal AG Germany 5.68 Completed
7 12.02.1999 AstraZeneca PLC Agrochemicals Switzerland 5.06 Completed
8 05.07.2001 Roche Holding AG Switzerland 2.79 Completed
9 12.31.2002 Roche Holding AG Switzerland 2.58 Completed
10 01.21.1998 Allied Colloids Group PLC United Kingdom 2.31 Completed

Are you sure you
want to log out?

In order to become a charterholder you need to complete one of the IMAA programs